Meningiomas are the most common intracranial tumors. Yet, only few controlled clinical trials have been conducted to guide clinical decision making, resulting in variations of management approaches across countries and centers. However, recent advances in molecular genetics and clinical trial results help to refine the diagnostic and therapeutic approach to meningioma. Accordingly, the European Association of Neuro-Oncology (EANO) updated its recommendations for the diagnosis and treatment of meningiomas.
Click here to read published version
Roland Goldbrunner, MD, Pantelis Stavrinou, MD, Michael D Jenkinson, MD, Felix Sahm, MD, Christian Mawrin, MD, Damien C Weber, MD, Matthias Preusser, MD, Giuseppe Minniti, MD, Morten Lund-Johansen, MD, Florence Lefranc, MD, Emanuel Houdart, MD, Kita Sallabanda, MD, Emilie Le Rhun, MD, David Nieuwenhuizen, MD, Ghazaleh Tabatabai, MD, Riccardo Soffietti, MD, Michael Weller, MD, EANO guideline on the diagnosis and management of meningiomas, Neuro-Oncology, 2021;, noab150, https://doi.org/10.1093/neuonc/noab150